These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 14963406)
1. Low dose fractionated radiation potentiates the effects of taxotere in nude mice xenografts of squamous cell carcinoma of head and neck. Spring PM; Arnold SM; Shajahan S; Brown B; Dey S; Lele SM; Valentino J; Jones R; Mohiuddin M; Ahmed MM Cell Cycle; 2004 Apr; 3(4):479-85. PubMed ID: 14963406 [TBL] [Abstract][Full Text] [Related]
2. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Dey S; Spring PM; Arnold S; Valentino J; Chendil D; Regine WF; Mohiuddin M; Ahmed MM Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432 [TBL] [Abstract][Full Text] [Related]
3. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck. Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168 [TBL] [Abstract][Full Text] [Related]
4. Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells. Gupta S; Koru-Sengul T; Arnold SM; Devi GR; Mohiuddin M; Ahmed MM Mol Cancer Ther; 2011 Feb; 10(2):292-302. PubMed ID: 21216938 [TBL] [Abstract][Full Text] [Related]
5. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360 [TBL] [Abstract][Full Text] [Related]
6. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts. Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789 [TBL] [Abstract][Full Text] [Related]
7. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215 [TBL] [Abstract][Full Text] [Related]
9. Heat-induced growth inhibition and apoptosis in transplanted human head and neck squamous cell carcinomas with different status of p53. Tamamoto T; Yoshimura H; Takahashi A; Asakawa I; Ota I; Nakagawa H; Ohnishi K; Ohishi H; Ohnishi T Int J Hyperthermia; 2003; 19(6):590-7. PubMed ID: 14756450 [TBL] [Abstract][Full Text] [Related]
10. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Huang SM; Harari PM Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065 [TBL] [Abstract][Full Text] [Related]
11. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma. Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1). Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646 [TBL] [Abstract][Full Text] [Related]
13. Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells. Shareef MM; Brown B; Shajahan S; Sathishkumar S; Arnold SM; Mohiuddin M; Ahmed MM; Spring PM Mol Cancer Res; 2008 Jan; 6(1):89-98. PubMed ID: 18234965 [TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma. Guo B; Cao S; Tóth K; Azrak RG; Rustum YM Clin Cancer Res; 2000 Feb; 6(2):718-24. PubMed ID: 10690558 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378 [TBL] [Abstract][Full Text] [Related]
17. C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy. Nakata E; Hunter N; Mason K; Fan Z; Ang KK; Milas L Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1163-73. PubMed ID: 15234052 [TBL] [Abstract][Full Text] [Related]
18. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer. Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of combined nedaplatin and docetaxel therapy for human head and neck cancer in vivo. Yamada H; Maki H; Takeda Y; Orita S Anticancer Res; 2006; 26(2A):989-94. PubMed ID: 16619497 [TBL] [Abstract][Full Text] [Related]
20. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Huang SM; Li J; Armstrong EA; Harari PM Cancer Res; 2002 Aug; 62(15):4300-6. PubMed ID: 12154033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]